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In the present study we collected 177 serum samples from ostriches (Struthio camelus) infected
experimentally with A/ostrich/South Africa/Middleton/2004 (H5N2) highly pathogenic avian influenza
virus. We tested these samples using the haemagglutination inhibition (HI) test, the agar gel immunodiffu-
sion test and three enzyme-linked immunosorbent assay kits. We considered the HI test, with homologous
antigen and including pre-treatment of sera with 10% chicken red blood cells, as the gold standard.
Detectable specific antibodies appeared on day 7 post-infection and persisted until the termination of the
experiment. The relative sensitivity and specificity of the tests under evaluation and Cohen’s K value were
calculated. The results reported herein could be of assistance to decision-makers in drafting guidelines for
the definition of the health status of ostriches and for trade purposes.
Introduction
Despite the inclusion of ostriches (Struthio camelus)i n
the World Organisation for Animal Health (OIE, 2008b)
and European Union (EU, 1990) definitions of ‘‘poul-
try’’ (Terrestrial Animal Health Code, 2008 and 1990/
539/EEC), they are phylogenetically*and thus anato-
mically and physiologically*very different from conven-
tional poultry.
Ostriches are classified in the superorder Paleog-
nathae, order Ratites, suborder Struthioniformes, family
Struthionidae (Vigors, 1825)*distant from the Galloan-
seriformes that belong to a different superorder the
Neognathae (Feduccia, 1999; Edward et al., 2002). They
are considered prehistoric birds (Cracraft, 1974) due to
certain peculiarities, among which is the absence of a
proper bursa of Fabricius (lymphoid tissue enclosed in
the dorsal and lateral tissue of the proctodeum), and this
is believed to influence the immune response of these
birds to pathogens (Huchzermeyer, 1994).
It has been reported that ostriches have an atypical
response to avian influenza (AI) infection. Both in
natural and experimental infection it has been reported
that both low pathogenicity AI and highly pathogenic
(HP) AI viruses cause a very similar clinical condition in
this species, with non-specific clinical signs and mortality
occurring only in young birds despite extensive virus
replication (Manvell et al., 1998; Capua et al., 2000,
Mutinelli et al., 2003; Olivier, 2006).
AI in its notifiable form must be reported to the OIE
and to the veterinary authorities of most countries.
A suspicion must be followed by a laboratory confirma-
tion, and, given the non-lethal nature of infection in
ostriches, a serological analysis may be a tool to support
diagnostic efforts and complement virus isolation or
detection methods. To date there is a paucity of data on
the reliability of serological assays performed on ostrich
sera, and in general there is a lack of validation data for
most infectious diseases of ostriches.
Scientific literature dealing with ostrich serology for
the detection of AI antibodies is limited and most of it
does not report data on the sensitivity or specificity of
the tests used, due to the lack of availability of
appropriate samples.
Zhou et al. (1998) tested 1261 ostrich sera collected
from farms in the US and Canada by agar gel
immunodiffusion (AGID), haemagglutination inhibition
(HI) and competitive enzyme-linked immunosorbent
assay (ELISA). Given the limited number of positive
samples, it was not possible to evaluate the performances
of the different tests. However, Zhou et al. demonstrated
that AGID was not a sensitive test compared with HI
and competitive ELISA because it was able to detect
only one of the 29 samples that were positive by HI and
competitive ELISA.
Ley et al. (2000) found only one positive AI sample by
HI among 163 ostrich sera collected in a US slaughter-
house, and Sakai et al. (2006) failed in finding any
positive samples among 181 ostrich sera collected in a
Japanese slaughterhouse using AGID.
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DOI: 10.1080/03079450903431390Clavjo et al. (2003) tested sera after an experimental
challenge of 22 ostriches infected with 10
6.6 median
embryo infective dose/ml H5N2 HPAI. In this experi-
ment, ostriches started to show low titred seroconversion
by HI and competitive ELISA from day 7 post-infection
until 14 day post-infection. The sensitivity of the AGID
was shown to be lower than HI and ELISA.
Other experimental infections reported by Manvell
et al. (1998, 2003) showed detectable seroconversion by
HI in a group of 10 birds infected with both HPAI and
low pathogenicity AI H5 and H7 viruses, using HI with
ostrich red blood cells (RBCs).
The data currently available are essentially insufficient
to make any statement on recommended diagnostic tests
for serology of AI in ostriches. The aim of the present
experiment was to test a significant number of ostrich
serum samples collected during an experimental infec-
tion by means of different serological assays in order to
establish which test(s) may be recommended for trade or
diagnostic purposes.
Materials and Methods
Experimental protocol and collection of samples. Thirty-three, 3-month-
old to 4-month-old ostriches were infected with 3 ml solution
containing 10
9 median embryo infective dose/0.1 ml A/ostrich/South
Africa/Middleton/2004 (H5N2) HPAI virus. One millilitre of the
inoculum was placed in one eye, 1 ml in one nostril and 1 ml in the
trachea. The challenge virus was supplied by the Virology Division,
Onderstepoort Veterinary Institute and the animal challenge experi-
ment was carried out in Onderstepoort Veterinary Institute*Exotic
Diseases Division.
At 0, 3 or 5 days post-infection (pi), 7 or 10 pi, 13 or 15 or 18 pi and
21 days post-infection, ostriches were bled to obtain serum samples in
sufficient amount to be tested by different methods. In total 177 serum
samples were collected. Serum samples were heat inactivated (568Cf o r
30 min) and stored at  208C until testing.
Serological tests. Each serum sample was tested by the following
serological tests.
Haemagglutination inhibition. HI tests were performed according to the
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (OIE,
2008a). Briefly serum samples were tested in ‘‘V’’-bottom plates using 4
haemagglutinating units of two different antigens. Namely, we used the
challenge strain A/ostrich/South Africa/Middleton/2004 (H5N2) as a
homologous antigen and a heterologous genetically distant H5N2 virus
(A/turkey/Italy/80).
Each serum sample was tested by HI with and without pre-
treatment with 10% chicken RBCs. The pre-treatment of the sera
with RBC solution was performed as follows (OIE, 2008a): 50 ml
phosphate-buffered saline (PBS) were dispensed into wells in the first
column of a microplate (wells A1 to E1), and the second row (A2 to
E2) was left empty. Then 25 ml PBS were subsequently dispensed into
all other wells of the microtitre plate. A 50 ml sample of test sera was
added to the first wells of the microplate (column 1) and then 50 mlo f
a 10% RBC suspension was added to the first wells (column 1). The
plates were incubated for 30 to 40 min at room temperature ( 20 to
248C), to allow to the 10% RBC suspension to settle. Subsequently,
25 ml supernatant of the samples in the first column was transferred to
the wells of the second column. An additional 25 ml supernatant from
the wells of the first column was transferred to the wells of the third
column. Two-fold serial dilutions of the samples in the third column
were performed, and the last 25 ml were discarded. From this point
onwards the sera were processed as chicken sera. The first column was
excluded from the test.
Agar gel immunodiffusion test. The AGID test was performed as
described by Beard (1970) and according to the OIE diagnostic manual
(OIE, 2008a).
Competitive ELISA test. A competitive IZSVe ELISA detecting
antibodies against AI nucleoprotein developed and validated at the
Istituto Zooprofilattico Sperimentale delle Venezie was used. Briefly,
ELISA plates (Maxisorp, Nunc) were coated overnight with an antigen
containing the whole purified virus (H5N2 A/turkey/Italy/80) with
coating buffer (pH 9.6). Sera were diluted 1:10 in a solution of sterile
PBS containing 1% yeast extract and 4% foetal calf serum. Then 50 ml
of each serum were distributed into wells and incubated for 1 h at 378C.
After washing the plates three times, an anti-nucleoprotein monoclonal
antibody developed in the framework of the FLUAID EC funded
project and conjugated with horseradish peroxidase was added and
incubated for 1 h at 378C. The plate was washed three times and the
substrate solution added. The reaction was stopped after 10 min
incubation in the dark and the optical density was read. Samples
obtaining a percentage of inhibition ]40% of the negative controls
were considered positive.
Two commercially available competitive ELISA kits (here called
COM. ELISA 1 and COM. ELISA 2) were also used following the
manufacturer’s instructions.
Statistical analysis. We considered the threshold of positivity recom-
mended by OIE and EU guidelines; that is, sera with an HI titre ]1:16
are considered positive. The HI performedwith the homologous antigen
following pre-treatment with a 10% chicken RBC suspension was
considered the gold standard method and was the reference test to
which other assays were compared. All sera under examination were
divided into two categories: positive samples (for ELISA this included
sera testing doubtful) and negative samples.
We calculated the sensitivity of each test from day 7 post infection
onwards, which previous tests have indicated as the date by which
antibodies are detectable.
The relative sensitivity (Se), relative specificity (Sp) and the relative
confidence interval (CI) were also calculated between each test (HI,
AGID and competitive ELISAs) and the gold standard chosen (Everitt,
1989).
The McNemar test and Cohen’s agreement value (K) were then
calculated (Cohen, 1960).
Results
Following challenge, almost all birds exhibited respira-
tory signs, such as conjunctivitis, ocular discharge, nasal
discharge, tracheal foam, pharyngitis and coughing. A
few birds showed diarrhoea. The average duration of
clinical signs was 5 days with a range from 1 to 11 days.
Eight birds showed clinical signs for a single day only. In
general, the birds recovered rapidly and, despite the high
dose of infection, clinical signs were mild (A. Olivier,
personal observation).
The sensitivity of each different test/methods is
presented in Table 1.
The relative Se and Sp, the results of Cohen’s and
McNemar’s tests of each method compared with the
gold standard (HI with RBCs 10% pre-treatment) and
the sensitivity of each method at different days post-
infection are presented in Tables 2 and 3, respectively.
We arbitrarily considered as false positive results the
ELISA readings at days 0 and 3. All tests under
examination were able to detect a variable percentage
of serologically positive birds from day 7 onwards. With
the exception of AGID, all tests exhibited a sensitivity
value over 70% by day 9 post-infection. Detailed results
on the onset and duration of antibody response are
shown in Table 4 and Figure 1.
12 A. Toffan et al.Table 2. Relative sensitivity and speciﬁcity, agreement (K) and P value of McNemar test of the different tests/methods compared
with the gold standard
Test/method
Se (confidence
interval)
Sp (confidence
interval)
Cohen’s K
(P value)
McNemar’s test
P value
HI with homologous antigen without pre-treatment 81.39 (71.55; 88.98) 98.84 (93.69; 99.97) 80.23 (B0.05) B0.05
HI with heterologous antigen without pre-treatment 27.91 (18.77; 38.62) 100 (95.80; 100*) 27.91 (B0.05) B0.05
HI with heterologous antigen and pre-treatment with
10% RBC solution
50 (23.04; 76.96) 93.75 (69.77; 99.84) 44.95 (B0.05) B0.10
COM. ELISA 1 91.86 (83.95; 96.66) 89.41 (80.85; 95.04) 82.28 (B0.05) NS
IZSVe ELISA 98.84 (93.69; 99.97) 86.05 (76.89; 92.58) 84.88 (B0.05) B0.05
COM. ELISA 2 97.64 (91.76; 99.71) 93.02 (85.43; 97.40) 90.65 (B0.05) NS
AGID 91.86 (86.95; 96.66) 97.67 (91.85; 99.71) 89.53 (B0.05) B0.10
Gold standard is HI with homologous antigen and pre-treatment with 10% RBC solution. *One-sided, 97.5% confidence interval.
NS, not significant.
Table 3. Sensitivity (conﬁdence interval) of the different tests at different days post-infection
Day post-infection COM. ELISA 1 COM. ELISA 2 IZSVe ELISA HI (gold standard) AGID
7 19.05 (5.45; 41.91) 33.33 (14.59; 56.97) 47.62 (25.71; 70.22) 19.05 (5.45; 41.91) 9.52 (1.17; 30.37)
9 90.90 (58.72; 99.77) 90.90 (58.72; 99.77) 90.90 (58.72; 97.77) 72.72 (39.03; 93.98) 54.54 (23.38; 83.25)
12 95.00 (75.13; 99.87) 95.00 (75.13; 99.87) 100 (83.16; 100*) 100 (83.16; 100*) 90.00 (68.30; 98.77)
15 100 (73.54; 100*) 100 (73.54; 100*) 100 (73.54; 100*) 100 (73.54; 100*) 100 (73.54; 100*)
18 100 (78.20; 100*) 93.75 (69.77, 99.84) 100 (79.41; 100*) 100 (76.84; 100*) 100 (79.41; 100*)
21 88.46 (69.85; 97.55) 96.00 (79.65; 99.90) 100 (87.23; 100*) 100 (85.75; 100*) 96.30 (81.03; 99.90)
22 60.00 (14.66; 94.73) 100 (47.82; 100*) 100 (47.82; 100*) 100 (47.82; 100*) 100 (47.82; 100*)
*One-sided, 97.5% confidence interval.
Table 1. Sensitivity of each test/method starting from day 7 post infection
Positive (confidence interval) Negative (confidence interval)
HI with homologous antigen without pre-treatment 67.57 (58.02; 76.15) 100 (94.48; 1*)
HI with homologous antigen and pre-treatment with 10%
RBC solution
80.37 (71.58; 87.42) 100 (94.48; 1*)
HI with heterologous antigen without pre-treatment 24.11 (16.53; 33.10) 100 (94.48; 1*)
HI with heterologous antigen and pre-treatment with 10%
RBCs solution
45.00 (23.06; 68.47) 100 (73.54; 1*)
COM. ELISA 1 78.18 (69.30; 85.49) 92.19 (82.70; 97.41)
COM. ELISA 2 83.64 (75.38; 90.00) 100 (94.48; 1*)
IZSVe ELISA 89.29 (93.70; 99.78) 96.92 (89.32; 99.63)
AGID 75.89 (66.90; 83.47) 100 (94.48; 1*)
*One-sided, 97.5% confidence interval.
Table 4. Percentage of positive birds after infection during the study period obtained by different tests
Day post-infection COM. ELISA 1 COM. ELISA 2 IZSVe ELISA HI (gold standard) AGID Expected result
0 12.50 0.00 0.00 0.00 0.00 0.00
3 5.00 0.00 10.00 0.00 0.00 0.00
5 0.00 0.00 0.00 0.00 0.00 0.00
7 19.05 33.33 47.62 19.05 9.52 100.00
9 90.91 90.91 90.91 72.73 54.55 100.00
12 95.00 95.00 100.00 100.00 90.00 100.00
15 100.00 100.00 100.00 100.00 100.00 100.00
18 100.00 93.75 100.00 100.00 100.00 100.00
21 88.46 96.00 100.00 100.00 96.30 100.00
22 60.00 100.00 100.00 100.00 100.00 100.00
Serological tests for Avian Influenza antibodies in ostriches 13The results of Cohen’s K test, measuring the agreement
between the test results at different days post infection
and the expected results, are reported in Table 5.
Discussion
The present study has enabled us to compare the ability
of different serological tests to detect antibodies against
AI virus in serum samples collected from experimentally
infected ostriches. A total of 177 serum samples from 33
birds were tested. To our knowledge this is the first study
on ostrich serology supported by a statistically signifi-
cant number of samples.
All serum samples have been analysed with three
different test systems, namely HI, AGID and competi-
tive ELISA. To gather as much information as possible,
we applied different methods for HI (with and without
10% chicken erythrocyte pre-treatment and with two
different antigens), and for ELISA (three different
competitive kits).
Previous work (Zhou et al., 1998) indicated that
AGID is not a satisfactory test because of its low
sensitivity. In our experiment the sensitivity was lower
compared with that of the other tests but after day 12
post-infection the sensitivity of the test was surprisingly
high. However, it was very difficult to read the plates
because the precipitation lines were often extremely thin
and at times incomplete.
It has been often reported (Williams et al., 1997;
Manvell et al., 1998; Sakai et al., 2006) that ostrich sera
are highly cross-reactive when tested by HI for the
presence of non-specific inhibitors of haemagglutination
with the consequence of a high number of false positives.
On the other hand, false negatives could also occur with
ostrich sera. This could be due to the fact that ostrich
sera may cause non-specific agglutination of chicken
RBCs. Some authors (Manvell et al., 1998) tested ostrich
sera using ostrich RBCs, but this method it is not
generally recommended as it has not been validated.
Sera tested in this study did not exhibit any non-
specific haemagglutination inhibition artefact in negative
(pre-challenge) samples, regardless of pre-treatment.
The HI test, when performed with homologous
antigen (challenge virus), was found to be a sensitive
and specific test. Pre-treatment with 10% chicken RBC
suspension increased the sensitivity of the test and aided
the interpretation of results by eliminating non-specific
agglutination of chicken RBCs that was observed in
certain samples. Interestingly, this was seen only in
samples collected from the same animals (2/33 birds),
thus suggesting that it could be related to the character-
istics of the individual.
Notwithstanding the results obtained using the chal-
lenge virus as an antigen, the results generated using
another virus (of the same H and N subtype) as a
haemagglutinating antigen (HA) were not satisfactory.
We therefore recommend that if the field virus is not
available, a selection of viruses should be used in order to
identify the most suitable antigen.
Generally speaking the ELISA tests used all yielded
comparable results with high Se and Sp and substantial
agreement with the gold standard. Using ELISA tests,
antibodies could be detected in the sera of experimen-
tally infected ostriches from day 7 post infection,
exhibiting sensitivity values greater than or equal to
the HI (Table 4). Two of the ELISA kits used produced
apparently false positive results within day 5 post-
infection. It also appeared that one of the commercial
kits was unable to maintain high sensitivity values
towards the termination of the experiment.
In conclusion, we believe that the results of the present
study may give indications as to which tests can be used
for serological diagnosis of AI virus infections in
ostriches. We conclude that validated ELISA tests for
the detection of AI antibodies in ostrich sera can be
considered suitable tests for screening purposes and
should be preferred to AGID. The HI test with pre-
treatment with 10% chicken RBC suspension, and using
the virus to which the birds have been exposed (or
genetically and antigenically closely related with it) as
the HA, remains a suitable test to monitor the circula-
tion of AI virus of known subtype.
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Figure 1. Percentage of positive birds after infection during the
study period compared with the expected result.
Table 5. Cohen’s agreement (K) of different tests with the expected result
Days COM. ELISA 1 COM. ELISA 2 IZSVe ELISA AGID HI (gold standard)
0 to 7 0.1390
$ 0.4305** 0.5210** 0.1373** 0.2624**
0 to 9 0.7222** 0.9448** 0.8464** 0.6724** 0.8202**
0 to 12 0.8158** 0.9667** 0.9368** 0.9323** 1**
0 to 15 0.7884** 1** 0.9076** 1** 1**
0 to 18 0.8176** 0.9601** 0.9256** 1** 1**
0 to 22 0.4088** 1** 0.8182** 1** 1**
**PB0.01, *PB0.05,
$PB0.10. To better understand the results, use the Landis & Koch scale: 50.01 poor agreement; 0.02 to
0.20 slight agreement; 0.21 to 0.40 fair agreement; 0.41 to 0.60 moderate agreement; 0.61 to 0.80 substantial agreement; 0.81 to
1.00 almost perfect agreement.
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